DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Chiorean EG, Von Hoff DD, Tabernero J. et al.
Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer.
Br J Cancer 2016;
115: 188-194
We do not assume any responsibility for the contents of the web pages of other providers.